M&T Bank Corp Axogen, Inc. Transaction History

M&T Bank Corp

$30.1 Billion
Q3 2024

A detailed history of M&T Bank Corp transactions in Axogen, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 34,682 shares of AXGN stock, worth $639,189. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,682

Previous 34,682 -0.0%

Holding current value

$639,189

Previous $486,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$7.52 - $14.69 $269,411 - $526,283	-35,826 Reduced 50.81%	34,682 $486,000
Q2 2024 Jul 31, 2024	BUY	$5.67 - $8.06 $44,328 - $63,013	7,818 Added 12.47%	70,508 $510,000
Q1 2024 May 07, 2024	BUY	$6.63 - $10.69 $39,183 - $63,177	5,910 Added 10.41%	62,690 $505,000
Q4 2023 Feb 06, 2024	BUY	$3.61 - $7.76 $31,565 - $67,853	8,744 Added 18.2%	56,780 $387,000
Q3 2023 Nov 02, 2023	BUY	$4.68 - $9.26 $50,066 - $99,063	10,698 Added 28.65%	48,036 $240,000
Q2 2023 Aug 09, 2023	BUY	$8.5 - $10.38 $39,474 - $48,204	4,644 Added 14.2%	37,338 $340,000
Q4 2022 Feb 13, 2023	BUY	$9.44 - $13.09 $124,041 - $172,002	13,140 Added 67.2%	32,694 $326,000
Q4 2022 Feb 13, 2023	SELL	$9.44 - $13.09 $237,312 - $329,069	-25,139 Reduced 56.25%	19,554 $195,000
Q3 2022 Nov 14, 2022	SELL	$8.14 - $12.25 $65,486 - $98,551	-8,045 Reduced 15.25%	44,693 $533,000
Q2 2022 Aug 05, 2022	BUY	$6.99 - $10.0 $31,468 - $45,020	4,502 Added 9.33%	52,738 $432,000
Q1 2022 May 09, 2022	BUY	$7.26 - $10.7 $175,096 - $258,062	24,118 Added 100.0%	48,236 $382,000
Q4 2021 Feb 07, 2022	BUY	$8.8 - $16.0 $11,580 - $21,056	1,316 Added 5.77%	24,118 $226,000
Q3 2021 Oct 28, 2021	BUY	$15.23 - $21.72 $10,386 - $14,813	682 Added 3.08%	22,802 $360,000
Q2 2021 Aug 13, 2021	SELL	$17.8 - $23.5 $36,632 - $48,363	-2,058 Reduced 8.51%	22,120 $478,000
Q1 2021 May 06, 2021	SELL	$17.18 - $22.6 $3,521 - $4,633	-205 Reduced 0.84%	24,178 $490,000
Q3 2020 Nov 06, 2020	BUY	$10.62 - $13.12 $57,337 - $70,834	5,399 Added 28.44%	24,383 $284,000
Q2 2020 Jul 29, 2020	BUY	$7.35 - $10.81 $9,437 - $13,880	1,284 Added 7.25%	18,984 $175,000
Q1 2020 May 14, 2020	BUY	$8.38 - $17.34 $13,215 - $27,345	1,577 Added 9.78%	17,700 $184,000
Q4 2019 Feb 07, 2020	BUY	$11.18 - $18.6 $32,231 - $53,623	2,883 Added 21.77%	16,123 $288,000
Q3 2019 Nov 12, 2019	BUY	$12.09 - $20.46 $23,200 - $39,262	1,919 Added 16.95%	13,240 $165,000
Q2 2019 Aug 12, 2019	SELL	$18.5 - $25.47 $51,929 - $71,494	-2,807 Reduced 19.87%	11,321 $224,000
Q1 2019 May 15, 2019	BUY	$14.62 - $22.13 $206,551 - $312,652	14,128 New	14,128 $298,000

Others Institutions Holding AXGN

# of Institutions

163

Shares Held

36.1M

Call Options Held

230K

Put Options Held

400

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $779M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account